Kompozycja farmaceutyczna do kontrolowanego uwalniania

• 收藏
• 分享

专利权人:

Astellas Pharma Inc.

发明人:

TAKAISHI, YUUKI,NAKAMURA, SOICHIRO,TAKAHASHI, YUTAKA

申请号：

PL11762748

公开号：

PL2554168T3

申请日:

2011.03.28

申请国别(地区):

PL

年份:

2018

代理人:

摘要：

A pharmaceutical composition for modified release comprising (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, and a carrier for a sustained release pharmaceutical composition, wherein a maximum blood drug concentration (Cmax) when administered in a fasted state is 400 ng/mL or less, is disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/